Results 21 to 30 of about 100,300 (318)

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

open access: yesBritish medical journal, 2018
Objective To show that limiting dual antiplatelet therapy (DAPT) to six months in patients with event-free ST-elevation myocardial infarction (STEMI) results in a non-inferior clinical outcome versus DAPT for 12 months.
Elvin Kedhi   +17 more
semanticscholar   +1 more source

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

open access: yesHeart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga   +1 more
doaj   +1 more source

A mixed treatment comparison for short- and long-term outcomes of bare metal and drug eluting coronary stents [PDF]

open access: yes, 2016
Background The increasing use of drug eluting stents in interventional cardiology calls for assessment of their efficacy and safety, both among drug eluting and bare-metal stents, in the context of rational decision making.
Dias, Sofia, Petrou, Panagiotis
core   +2 more sources

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

open access: yesCoronary Artery Disease, 2019
Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Wang, Guozhong   +5 more
openaire   +3 more sources

Drug-eluting stent thrombosis [PDF]

open access: yesTherapeutic Advances in Cardiovascular Disease, 2009
Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS).
Stähli, B E, Camici, G G, Tanner, F C
openaire   +3 more sources

High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The Randomized PREPARE-CALC Trial

open access: yesCirculation. Cardiovascular Interventions, 2018
Background: Balloon dilatation or debulking seems to be essential to allow successful stent implantation in calcified coronary lesions. Compared with standard balloon predilatation, debulking using high-speed rotational atherectomy (RA) is associated ...
M. Abdel-Wahab   +11 more
semanticscholar   +1 more source

Stent implant follow-up in intravascular optical coherence tomography images [PDF]

open access: yes, 2009
The objectives of this article are (i) to utilize computer methods in detection of stent struts imaged in vivo by optical coherence tomography (OCT) during percutaneous coronary interventions (PCI); (ii) to provide measurements for the assessment ...
Carlier, Stephane Guy   +4 more
core   +2 more sources

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

open access: yesSAGE Open Medical Case Reports, 2016
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan   +2 more
doaj   +1 more source

The Drug-Eluting Stent Saga [PDF]

open access: yesCirculation, 2009
Drug-eluting stents (DES) represent a breakthrough technology owing to their potent reduction of restenosis, which is a nuisance in the quality of life of affected patients, a rare cause of myocardial infarction (MI), and the principal shortcoming of stents compared with coronary artery bypass surgery.
Windecker, Stephan, Jüni, Peter
openaire   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

open access: yes, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M   +6 more
core   +3 more sources

Home - About - Disclaimer - Privacy